ProBiotix Health PLC - Wakefield, England-based life sciences business developing probiotics to tackle cardiovascular disease and other lifestyle conditions - Announces commercial partnership with Copenhagen-based DanCare Health for the sale of ProBiotix’s food supplement dosage format InstaMelt. Under the agreement, the ‘turnkey, direct dose stick solution that melts instantly on the tongue’ will be sold in China under the DanCare brand following its launch in the fourth quarter.
Chief Executive Officer Steen Andersen says: ‘DanCare is well-recognised in the Chinese market as a high-quality innovative brand. With cardiovascular disease on the rise and almost 155 million Chinese adults estimated to have elevated cholesterol levels, there is an increasing consumer focus on cardiometabolic health. With our product offering and cooperation with a market leader like DanCare we are well positioned to tap into this lucrative market over the years to come.’
Current share price: 4.00 pence
12-month change: down 56%
Copyright 2024 Alliance News Ltd. All Rights Reserved.
